Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Could U.S./EU Trade Pact Let Pharma Fight EU Drug Cost Controls In Court?

This article was originally published in The Pink Sheet Daily

Executive Summary

As the European Union and the U.S. reopen talks over the Transatlantic Trade and Investment Partnership (TTIP), opponents warn its so-called Investor-State Dispute Settlement mechanism could be exploited by pharmaceutical groups, undermining efforts by member states to control their drug spending.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS077448

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel